Search research articles
Contact Us
Filters
Showing results (101-110 of 116) with videos related to
Page
of 12
Sort By:
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
May 1, 1996
Phase Ia/Ib trial of anti-GD2 chimeric monoclonal antibody 14.18 (ch14.18) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in metastatic melanoma
J L Murray, E S Kleinerman, S F Jia, et al.
Annals of Surgery
|
September 1, 1996
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger
C M Balch, S J Soong, A A Bartolucci, et al.
American Journal of Surgery
|
September 27, 2000
The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy
G Vlastos, B D Fornage, N Q Mirza, et al.
Annals of Surgical Oncology
|
January 6, 2000
Primary tumor response to induction chemotherapy as a predictor of histological status of axillary nodes in operable breast cancer patients
J T Lenert, G Vlastos, N Q Mirza, et al.
The Cancer Journal From Scientific American
|
August 5, 1998
Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status
H M Kuerer, L A Newman, A U Buzdar, et al.
Annals of Surgical Oncology
|
July 14, 2000
Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancer
F Meric, N Q Mirza, A U Buzdar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2000
Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer
T M Breslin, L Cohen, A Sahin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 1999
Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy
H M Kuerer, L A Newman, T L Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma
O Eton, D D Kharkevitch, M A Gianan, et al.
Annals of Surgical Oncology
|
October 18, 2000
Ductal carcinoma-in-situ: long-term results of breast-conserving therapy
N Q Mirza, G Vlastos, F Meric, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 116) with videos related to
Sort By:
Page
of 12
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
May 1, 1996
Phase Ia/Ib trial of anti-GD2 chimeric monoclonal antibody 14.18 (ch14.18) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in metastatic melanoma
J L Murray, E S Kleinerman, S F Jia, et al.
Annals of Surgery
|
September 1, 1996
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger
C M Balch, S J Soong, A A Bartolucci, et al.
American Journal of Surgery
|
September 27, 2000
The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy
G Vlastos, B D Fornage, N Q Mirza, et al.
Annals of Surgical Oncology
|
January 6, 2000
Primary tumor response to induction chemotherapy as a predictor of histological status of axillary nodes in operable breast cancer patients
J T Lenert, G Vlastos, N Q Mirza, et al.
The Cancer Journal From Scientific American
|
August 5, 1998
Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status
H M Kuerer, L A Newman, A U Buzdar, et al.
Annals of Surgical Oncology
|
July 14, 2000
Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancer
F Meric, N Q Mirza, A U Buzdar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2000
Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer
T M Breslin, L Cohen, A Sahin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 1999
Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy
H M Kuerer, L A Newman, T L Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma
O Eton, D D Kharkevitch, M A Gianan, et al.
Annals of Surgical Oncology
|
October 18, 2000
Ductal carcinoma-in-situ: long-term results of breast-conserving therapy
N Q Mirza, G Vlastos, F Meric, et al.
Page
of 12